{"id":8856,"date":"2026-05-03T22:52:14","date_gmt":"2026-05-03T22:52:14","guid":{"rendered":"https:\/\/www.healthoptibody.com\/?p=8856"},"modified":"2026-05-05T15:57:58","modified_gmt":"2026-05-05T15:57:58","slug":"i-have-my-own-funeral-planned-down-to-the-smallest-detail-meet-irelands-death-doulas-who-specialise-in-making-the-dyings-final-days-as-easy-as-possible-and-help-ease-the-pain-for-those-they-l","status":"publish","type":"post","link":"https:\/\/www.healthoptibody.com\/?p=8856","title":{"rendered":"Pembrolizumab injection vs IV | NHS National Cancer Plan 2026 | Keytruda side effects"},"content":{"rendered":"

 <\/p>\n

\n

\ud83d\udcdd The 60-Second Breakthrough: NHS Immunotherapy Goes “Rapid”<\/h3>\n

The NHS is officially rolling out a revolutionary injectable form of immunotherapy that treats over a dozen different cancers in as little as 60 seconds<\/b>. This move is expected to transform the lives of roughly 14,000 patients<\/b> in England every year, slashing treatment times by a staggering 90%<\/b>.<\/p>\n

The drug, pembrolizumab<\/b> (brand name Keytruda<\/b>), was previously administered via an intravenous (IV) infusion that could take up to two hours per session. The new “jab” is a subcutaneous injection delivered into the fatty tissue of the abdomen or thigh.<\/p>\n

Which Cancers are Eligible?<\/b><\/h4>\n

The rapid jab is approved for 14 different types of cancer<\/b>, including:<\/p>\n

    \n
  • \n

    Lung Cancer<\/p>\n<\/li>\n

  • \n

    Breast Cancer<\/p>\n<\/li>\n

  • \n

    Head and Neck Cancers<\/p>\n<\/li>\n

  • \n

    Cervical Cancer<\/p>\n<\/li>\n<\/ul>\n

    \n
    \n
    \"Sarah<\/div>\n<\/div>\n

    Sarah Gardiner<\/p>\n<\/div>\n

    \ud83e\uddec How It Works: “Unmasking” the Disease<\/h3>\n

    Pembrolizumab is a form of immunotherapy<\/b>. Unlike traditional chemotherapy, which attacks all fast-growing cells, this drug “teaches” the body to fight back.<\/p>\n

      \n
    • \n

      The Target:<\/b> It blocks a protein called PD-1<\/b>.<\/p>\n<\/li>\n

    • \n

      The Mechanism:<\/b> PD-1 usually acts as a “brake” on the immune system. Cancer cells often hijack this protein to hide from immune responses.<\/p>\n<\/li>\n

    • \n

      The Result:<\/b> By blocking the “brake,” the drug allows the immune system to recognize and aggressively attack the cancer cells.<\/p>\n<\/li>\n<\/ul>\n

      \n

      \u23f1\ufe0f The Impact on NHS Capacity<\/h3>\n

      With a diagnosis made in the UK every 75 seconds<\/b>, the NHS is currently facing a capacity crisis. Last year, over 106,000 patients<\/b> waited more than 62 days for urgent treatment.<\/p>\n\n\n\n\n\n\n\n\n
      Feature<\/strong><\/td>\nOld Method (IV Infusion)<\/strong><\/td>\nNew Method (Injection)<\/strong><\/td>\n<\/tr>\n<\/thead>\n
      Treatment Time<\/b><\/span><\/td>\nUp to 120 Minutes<\/span><\/td>\n1 to 2 Minutes<\/span><\/td>\n<\/tr>\n
      Frequency<\/b><\/span><\/td>\nEvery 3 to 6 weeks<\/span><\/td>\nEvery 3 to 6 weeks<\/span><\/td>\n<\/tr>\n
      Location<\/b><\/span><\/td>\nInfusion Unit Chair<\/span><\/td>\nGeneral Treatment Room<\/span><\/td>\n<\/tr>\n
      System Benefit<\/b><\/span><\/td>\nHigh resource\/staff time<\/span><\/td>\nFrees up clinical appointments<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

      Health Secretary Wes Streeting<\/b> noted that this rollout is a core part of the National Cancer Plan<\/b>, which aims to meet all existing cancer targets by March 2028<\/b> through innovation and the use of a “robotic revolution” to boost survival rates.<\/p>\n

      \n
      \n
      \"Bernadette<\/div>\n<\/div>\n

      Bernadette Kenny<\/p>\n<\/div>\n

      \u26a0\ufe0f Side Effects & Considerations<\/h3>\n

      While the rapid administration is a triumph of convenience, the underlying medicine remains a powerful metabolic therapy. Side effects occur regardless of whether the drug is injected or given via IV.<\/p>\n

      Common Side Effects:<\/b><\/p>\n

        \n
      • \n

        Hypothyroidism:<\/b> A drop in thyroid hormones can lead to fatigue, weight gain, and depression. Patients may require lifelong hormone replacement therapy.<\/p>\n<\/li>\n

      • \n

        Breathlessness:<\/b> Often caused by a drop in red blood cell counts.<\/p>\n<\/li>\n

      • \n

        Fluid Build-up:<\/b> General swelling or edema.<\/p>\n<\/li>\n<\/ul>\n

        Rare but Serious Risks:<\/b> In rare cases, the immune system can become overactive and attack healthy organs, leading to:<\/p>\n

          \n
        • \n

          Encephalitis<\/b> (brain inflammation)<\/p>\n<\/li>\n

        • \n

          Pancreatitis<\/b><\/p>\n<\/li>\n

        • \n

          Myocarditis<\/b> (heart inflammation)<\/p>\n<\/li>\n<\/ul>\n

          broke us.<\/p>\n

          \n
          \n
          \"Jessica<\/div>\n<\/div>\n

          Jessica Byrne<\/p>\n<\/div>\n

          \ud83d\udca1 The Takeaway<\/h3>\n

          For patients like 89-year-old Shirley Xerxes<\/b>, the first to receive the jab, the benefit is measured in hours reclaimed. “I was only in the chair for a matter of minutes instead of an hour or more,” she shared. “It gives me more time to live my life, including spending more time gardening.”<\/p>\n

          By making “every penny and every second count,” the NHS is betting that this 60-second solution will be a vital tool in bringing down the UK’s daunting cancer backlog.<\/p>\n

          \n

          Are you or a loved one currently navigating a cancer treatment plan? This shift to injections could significantly change your hospital schedule\u2014is this a move you’ve been waiting for?<\/b><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

            \ud83d\udcdd The 60-Second Breakthrough: NHS Immunotherapy Goes “Rapid” The NHS is officially rolling out a revolutionary injectable form of immunotherapy that treats over a dozen different cancers in as little as 60 seconds. This move is expected to transform the lives of roughly 14,000 patients in England every year, slashing treatment times by a<\/p>\n","protected":false},"author":1,"featured_media":8857,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[987],"tags":[3552,3948,2585,3947,1359,1363,3472,3949,2586,3421],"class_list":{"0":"post-8856","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthy-living","8":"tag-cancer-treatment","9":"tag-healthcare-efficiency","10":"tag-immunotherapy","11":"tag-keytruda","12":"tag-medical-innovation","13":"tag-nhs","14":"tag-oncology","15":"tag-patient-care","16":"tag-pembrolizumab","17":"tag-uk-health"},"_links":{"self":[{"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/posts\/8856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8856"}],"version-history":[{"count":2,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/posts\/8856\/revisions"}],"predecessor-version":[{"id":8970,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/posts\/8856\/revisions\/8970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=\/wp\/v2\/media\/8857"}],"wp:attachment":[{"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8856"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8856"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthoptibody.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}